The Drug Information Journal and the Drug Information Association Michael R. Hamrell From the Editor-in-Chief 30 December 2007 Pages: xi - xi
Unwanted Immunogenicity: Implications for Follow-on Biologicals Meenu WadhwaRobin Thorpe Drug Development 30 December 2007 Pages: 1 - 9
Bayesian Data Mining Techniques: The Evidence Provided by Signals Detected in Single-Company Spontaneous Reports Databases Marina CesanaRenata CeruttiDavide Luciani Statistics 30 December 2007 Pages: 11 - 21
Consideration of Operational a Level with Different Approval Strategies Boguang Andy Zhen Statistics 30 December 2007 Pages: 23 - 29
Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America Walter OffenChristy Chuang-SteinChyon-Hwa Yeh Statistics 30 December 2007 Pages: 31 - 46
The Probability of Observing Negative Subgroup Results When the Treatment Effect is Positive and Homogeneous across All Subgroups Zhengqing LiChristy Chuang-SteinCyrus Hoseyni Statistics 30 December 2007 Pages: 47 - 56
Effective Risk Management Tools Jon Willem van der VeldenEveline Jaquenoud Sirot Risk Management 30 December 2007 Pages: 63 - 68
RAMP (Risk Assessment and Management Process): An Approach to Risk-Based Computer System Validation and Part 11 Compliance Richard M. SiconolfiSuzanne Bishop Risk Management 30 December 2007 Pages: 69 - 79
Risk Perception of Prescription Drugs: Results of a National Survey Paul SlovicEllen PetersGretchen S. Dieck Risk Management 30 December 2007 Pages: 81 - 100
Continuous Marketing Applications: Experiences of Three Biotechnology Companies Christine BoisclairMeg CasaisDonna Peterson Regulatory 30 December 2007 Pages: 101 - 109
A New Model for Communicating Risk Information in Direct-to-Consumer Print Advertisements Jennifer L. StotkaMatthew D. RotelliDavid R. McAvoy Communications 30 December 2007 Pages: 111 - 120
